Balancing the Need for Access With the Imperative for Empirical Evidence of Benefit and Risk.
Publication
, Journal Article
Califf, RM
Published in: JAMA
August 15, 2017
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
August 15, 2017
Volume
318
Issue
7
Start / End Page
614 / 616
Location
United States
Related Subject Headings
- Risk Assessment
- Risk
- Pharmaceutical Preparations
- Humans
- General & Internal Medicine
- Drug-Related Side Effects and Adverse Reactions
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M. (2017). Balancing the Need for Access With the Imperative for Empirical Evidence of Benefit and Risk. JAMA, 318(7), 614–616. https://doi.org/10.1001/jama.2017.9412
Califf, Robert M. “Balancing the Need for Access With the Imperative for Empirical Evidence of Benefit and Risk.” JAMA 318, no. 7 (August 15, 2017): 614–16. https://doi.org/10.1001/jama.2017.9412.
Califf RM. Balancing the Need for Access With the Imperative for Empirical Evidence of Benefit and Risk. JAMA. 2017 Aug 15;318(7):614–6.
Califf, Robert M. “Balancing the Need for Access With the Imperative for Empirical Evidence of Benefit and Risk.” JAMA, vol. 318, no. 7, Aug. 2017, pp. 614–16. Pubmed, doi:10.1001/jama.2017.9412.
Califf RM. Balancing the Need for Access With the Imperative for Empirical Evidence of Benefit and Risk. JAMA. 2017 Aug 15;318(7):614–616.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
August 15, 2017
Volume
318
Issue
7
Start / End Page
614 / 616
Location
United States
Related Subject Headings
- Risk Assessment
- Risk
- Pharmaceutical Preparations
- Humans
- General & Internal Medicine
- Drug-Related Side Effects and Adverse Reactions
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences